Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure

• Autors principals: K. Wegleiter (Autor), M. Waltner-Romen (Autor), R. Trawoeger (Autor), U. Kiechl-Kohlendorfer (Autor), E. Griesmaier (Autor)
• Format: Llibre
• Publicat: Hindawi Limited, 2018-01-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Fetal angiotensin II receptor antagonist exposure is associated with major complications and even death when administered during pregnancy. Neonates frequently require intensive care treatment, and mortality is high. Despite this well-known risk potential, a considerable number of women still receiv...